Nanotechnology platforms in Parkinson's Disease
Parkinson's disease (PD) remains a serious concern due to its effects on the quality of life of patients and its socioeconomic burden to society. Present day management of PD has limitations in both diagnosis and treatment. Nanotechnology may provide smart solutions to this problem. The present...
Saved in:
Main Authors: | Rishi Rajat Adhikary (Author), Puja Sandbhor (Author), Rinti Banerjee (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanotechnology-based drug delivery of ropinirole for Parkinson's disease
by: Emilia Barcia, et al.
Published: (2017) -
Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer's and Parkinson's Disease
by: Antea Krsek, et al.
Published: (2024) -
Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy
by: Geetha Maniam, et al.
Published: (2018) -
Phytosomes as an Emerging Nanotechnology Platform for the Topical Delivery of Bioactive Phytochemicals
by: Waleed S. Alharbi, et al.
Published: (2021) -
Alzheimer's and Parkinson's disease therapies in the clinic
by: Puja Chopade, et al.
Published: (2023)